AU2001294267A1 - Survivin-like polypeptides and dnas thereof - Google Patents

Survivin-like polypeptides and dnas thereof

Info

Publication number
AU2001294267A1
AU2001294267A1 AU2001294267A AU9426701A AU2001294267A1 AU 2001294267 A1 AU2001294267 A1 AU 2001294267A1 AU 2001294267 A AU2001294267 A AU 2001294267A AU 9426701 A AU9426701 A AU 9426701A AU 2001294267 A1 AU2001294267 A1 AU 2001294267A1
Authority
AU
Australia
Prior art keywords
survivin
dnas
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294267A
Inventor
Isao Kaieda
Hiroshi Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001294267A1 publication Critical patent/AU2001294267A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001294267A 2000-10-17 2001-10-16 Survivin-like polypeptides and dnas thereof Abandoned AU2001294267A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000316721 2000-10-17
JP2000-316721 2000-12-20
JP2000386809 2000-12-20
JP2000-386809 2000-12-20
PCT/JP2001/009071 WO2002033071A1 (en) 2000-10-17 2001-10-16 Survivin-like polypeptides and dnas thereof

Publications (1)

Publication Number Publication Date
AU2001294267A1 true AU2001294267A1 (en) 2002-04-29

Family

ID=26602237

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294267A Abandoned AU2001294267A1 (en) 2000-10-17 2001-10-16 Survivin-like polypeptides and dnas thereof

Country Status (2)

Country Link
AU (1) AU2001294267A1 (en)
WO (1) WO2002033071A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2415336T3 (en) 2003-04-11 2013-07-25 Survac Aps Therapeutic Cancer Vaccine
CA2563393C (en) * 2003-04-11 2018-05-01 Survac Aps Ml - iap peptides induce anti-melanoma cytotoxic t-cell response
CN1316037C (en) * 2003-12-19 2007-05-16 叶尚勉 Diagnostic reagent for detecting survivin expression level in sample to be detected, detection method and application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6472172B1 (en) * 1998-07-31 2002-10-29 Schering Aktiengesellschaft DNA encoding a novel human inhibitor-of-apoptosis protein
WO2000023589A2 (en) * 1998-10-20 2000-04-27 Incyte Pharmaceuticals, Inc. Proliferation and apoptosis related proteins
AU5544500A (en) * 1999-06-15 2001-01-02 Astrazeneca Ab Livin; inhibitor-of-apoptosis protein-3 (iap-3)

Also Published As

Publication number Publication date
WO2002033071A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001234944A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
AU2002246502A1 (en) Nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU2001241511A1 (en) Novel nucleic acids and polypeptides
AUPQ976800A0 (en) Novel polypeptides and polynucleotides and uses therefor
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
EP1357186A4 (en) Novel proteins and dnas thereof
WO2002016439A8 (en) Novel nucleic acids and polypeptides
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU2002330672A1 (en) Gmg-1 polynucleotides and polypeptides and uses thereof
AU2399601A (en) Novel tachykinin-like polypeptides and use thereof
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2002218199A1 (en) Truncated phosphodiesterase-7 polypeptides
AU2001263005A1 (en) Novel nucleic acids and polypeptides